133 related articles for article (PubMed ID: 34856570)
21. Transforming acidic coiled-coil protein-3: a novel marker for differential diagnosis and prognosis prediction in endocervical adenocarcinoma.
Wen YL; Yan SM; Wei W; Yang X; Zhang SW; Yun JP; Liu LL; Luo RZ
Mol Med; 2021 Jun; 27(1):60. PubMed ID: 34134633
[TBL] [Abstract][Full Text] [Related]
22. Carcinoma of the Uterine Cervix Involving the Genitourinary Tract: A Potential Diagnostic Dilemma.
Schwartz LE; Khani F; Bishop JA; Vang R; Epstein JI
Am J Surg Pathol; 2016 Jan; 40(1):27-35. PubMed ID: 26426382
[TBL] [Abstract][Full Text] [Related]
23. Synchronous and metachronous endocervical and ovarian neoplasms: evidence supporting interpretation of the ovarian neoplasms as metastatic endocervical adenocarcinomas simulating primary ovarian surface epithelial neoplasms.
Elishaev E; Gilks CB; Miller D; Srodon M; Kurman RJ; Ronnett BM
Am J Surg Pathol; 2005 Mar; 29(3):281-94. PubMed ID: 15725796
[TBL] [Abstract][Full Text] [Related]
24. Concordance Between Biopsy and Resection Diagnoses of Uterine Cervical Adenocarcinoma According to the Updated World Health Organization 2020 Classification: A Multi-Institutional Study Elucidating Real-World Practice in Japan.
Kawakami F; Yanai H; Teramoto N; Miyama Y; Yasuda M; Minamiguchi S; Iwamoto M; Kiyokawa T; Mikami Y
Arch Pathol Lab Med; 2024 Jan; ():. PubMed ID: 38282572
[TBL] [Abstract][Full Text] [Related]
25. Predicting prognosis according to the updated WHO classification in patients with endocervical adenocarcinoma treated with surgery and radiotherapy.
Cho WK; Kim HS; Park W; Chang CS; Lee YY; Choi CH; Kim TJ; Lee JW; Kim BG
J Gynecol Oncol; 2022 Nov; 33(6):e71. PubMed ID: 36047374
[TBL] [Abstract][Full Text] [Related]
26. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
[TBL] [Abstract][Full Text] [Related]
27. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
[TBL] [Abstract][Full Text] [Related]
28. A panel of 3 markers including p16, ProExC, or HPV ISH is optimal for distinguishing between primary endometrial and endocervical adenocarcinomas.
Kong CS; Beck AH; Longacre TA
Am J Surg Pathol; 2010 Jul; 34(7):915-26. PubMed ID: 20534993
[TBL] [Abstract][Full Text] [Related]
29. Membranous and nuclear staining of CLDN18 in HPV-independent and HPV-associated endocervical adenocarcinomas.
Du X; Hu Y; Ji X; Sui L; Zheng Q; Song K; Lv T; Chen Y; Zhao H; Dai S; Zhao P; Yao Q
Cancer Med; 2023 Jan; 12(2):1441-1450. PubMed ID: 35861118
[TBL] [Abstract][Full Text] [Related]
30. A retrospective study on incidence, diagnosis, and clinical outcome of gastric-type endocervical adenocarcinoma in a single institution.
Radomska A; Lee D; Neufeld H; Korte N; Torlakovic E; Agrawal A; Chibbar R
Diagn Pathol; 2021 Jul; 16(1):68. PubMed ID: 34332600
[TBL] [Abstract][Full Text] [Related]
31. Endometrial endometrioid adenocarcinoma of the uterine corpus involving the cervix: some cases probably represent independent primaries.
Jiang L; Malpica A; Deavers MT; Guo M; Villa LL; Nuovo G; Merino MJ; Silva EG
Int J Gynecol Pathol; 2010 Mar; 29(2):146-56. PubMed ID: 20173500
[TBL] [Abstract][Full Text] [Related]
32. Superficial (early) endocervical adenocarcinoma in situ: a study of 12 cases and comparison to conventional AIS.
Witkiewicz A; Lee KR; Brodsky G; Cviko A; Brodsky J; Crum CP
Am J Surg Pathol; 2005 Dec; 29(12):1609-14. PubMed ID: 16327433
[TBL] [Abstract][Full Text] [Related]
33. MRI characteristics for predicting histological subtypes in patients with uterine cervical adenocarcinoma.
Mori T; Kato H; Kawaguchi M; Kanayama T; Furui T; Noda Y; Hyodo F; Matsuo M
Eur J Radiol; 2023 Jan; 158():110612. PubMed ID: 36542931
[TBL] [Abstract][Full Text] [Related]
34. A Snapshot of the Landscape of Endocervical Adenocarcinoma in Kenya: What Has HPV Got to Do with It?
Wawire J; Njenga P; Moloo Z; Sung CJ; Quddus MR
Ann Clin Lab Sci; 2022 Jul; 52(4):621-627. PubMed ID: 36197776
[TBL] [Abstract][Full Text] [Related]
35. Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus.
Park KJ; Kiyokawa T; Soslow RA; Lamb CA; Oliva E; Zivanovic O; Juretzka MM; Pirog EC
Am J Surg Pathol; 2011 May; 35(5):633-46. PubMed ID: 21490443
[TBL] [Abstract][Full Text] [Related]
36. Cervical adenocarcinoma: integration of HPV status, pattern of invasion, morphology and molecular markers into classification.
Park KJ
Histopathology; 2020 Jan; 76(1):112-127. PubMed ID: 31846527
[TBL] [Abstract][Full Text] [Related]
37. The Updated World Health Organization Classification Better Predicts Survival in Patients With Endocervical Adenocarcinoma (KROG 20-07).
Cho WK; Kim HS; Park W; Kim YS; Kang J; Kim YB; Kim YS; Kim YJ; Kim KR; Kim JH; Kwon SY; Choi JH; Yoon M; Kim NI
Int J Radiat Oncol Biol Phys; 2023 Sep; 117(1):154-163. PubMed ID: 36935025
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological features and outcomes in gastric-type of HPV-independent endocervical adenocarcinomas.
Chen L; Niu Y; Wan X; Yu L; Zhang X; Strickland AL; Dong L; Zhou F; Lu W
BMC Cancer; 2021 Oct; 21(1):1095. PubMed ID: 34635081
[TBL] [Abstract][Full Text] [Related]
39. FIGO 2018 stage IB endocervical adenocarcinomas: an international study of outcomes informed by prognostic biomarkers.
Stolnicu S; Boros M; Hoang L; Almadani N; de Brot L; Baiocchi G; Bonvolim G; Parra-Herran C; Lerias S; Felix A; Roma A; Pesci A; Oliva E; Park K; Soslow RA; Abu-Rustum NR
Int J Gynecol Cancer; 2021 Feb; 31(2):177-184. PubMed ID: 33177150
[TBL] [Abstract][Full Text] [Related]
40. Molecular and pathological basis of HPV-negative cervical adenocarcinoma seen in a global study.
Jenkins D; Molijn A; Kazem S; Pirog EC; Alemany L; de Sanjosé S; Dinjens W; Quint W
Int J Cancer; 2020 Nov; 147(9):2526-2536. PubMed ID: 32474915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
